Relafen 750, or Relafen, or Naproxcinod, or the medication represents a targeted approach within pain management , viewed from a biochemical pharmacy perspective. The formulation, comprising naproxcinod, attempts to modulate cyclooxygenase (COX) activity, notably COX-2, although demonstrating lim